a) Countries where the systems operate | |
b) The extent of data collection (e.g. community services, facilities services) | |
c) The main purpose of the system d) Records linkage | |
e) The level of implementation (e.g. local, national) | |
f) Target population (e.g. specified subgroups or total population) | |
g) The data collection form used (e.g. electronic, paper) | |
h) Whether the data entered into the registry was primary data, or if the registry was based on secondary data from pre-existing sources. | |
i) MNCHcare periods that the system registers | |
j) Whether it collects the MNCH variables defined by the GAIA project | |
k) Whether it collects socio-demographic data, obstetric information, pre-existing conditions of each women, and antenatal care outcome process. | |
l) Type of code for classification of diseases used | |
m) The individual data capture process (how and where it is done) | |
n) Baseline data (pregnancy and outcomes) timeframe | |
o) Capability to import, compile and export electronic data. | |
p) Capability to link individual MNCH data with other registers(e.g. laboratory records, expense drug records, vaccine registers) | |
q) Type of monitoring to assess data quality | |
r) Whether it has a back-up policy. | |
s) Availability of data collection tools and system documentation | |
t) Maintenance and update process | |
u) Whether it has data access policies, | |
v) Type of privacy protection | |
w) Funding or sponsor of each system | |
x) Prior use in active surveillance or pharmacovigilance or post-marketing surveillance. |